| Ytd | 7.60% | |
| 1y | 11.57% |
| Open | 21.68 | Prev Close | 21.58 | Low | 21.44 | High | 21.70 | Mkt Cap | 1.59B |
| Vol | 76.80K | Avg Vol | 826.05K | EPS | 4.23 | P/E | 5.10 | Forward P/E | 11.07 |
| Beta | 0.34 | Short Ratio | 7.09 | Inst. Own | 108.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 09-08 | Earning | 08-05 | 50-d Avg | 22.35 | 200-d Avg | 21.36 | 1yr Est | 35.50 |
INVA News
Nortiva Bio, Inc. (âNortivaâ) today announced its launch as a clinical-stage biopharmaceutical c
LEXINGTON, Mass.--(BUSINESS WIRE)--Nortiva Bio, Inc. (“Nortiva”) today announced its launch as a cli
WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Na
Innoviva, Inc. (INVA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transc
Innoviva, Inc. (NASDAQ: INVA) (âInnovivaâ or the âCompanyâ), a diversified biopharmaceutical
BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a
Innoviva develops respiratory pharmaceuticals through strategic partnerships and royalty agreements
Innoviva (INVA) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Est
BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a
Merck (MRK) came out with a quarterly loss of $1.28 per share versus the Zacks Consensus Estimate of
Shares of Innoviva, Inc. (NASDAQ: INVA - Get Free Report) have been assigned a consensus rating of "
The price-to-earnings (P/E) ratio is a commonly used metric that provides a snapshot of a company's
Innoviva, Inc. (NASDAQ: INVA - Get Free Report)'s stock price passed above its two hundred day movin
Shares of Innoviva, Inc. (NASDAQ: INVA - Get Free Report) have earned a consensus rating of "Moderat
WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc., tod
Innoviva, Inc. (INVA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transc
Innoviva, Inc. (NASDAQ: INVA - Get Free Report) has been given an average recommendation of "Moderat
BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a
BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a
SG Americas Securities LLC grew its position in shares of Innoviva, Inc. (NASDAQ: INVA) by 134.4% du
On Thursday, 1076 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Monday